強迫性障害治療の世界市場 2020年

• 英文タイトル：Global Obsessive-Compulsive Disorder Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114679 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、強迫性障害治療の世界市場を調査対象にし、強迫性障害治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ADX-88178、ビトペルチン、CR-5542、Dipraglurant IR、フルボキサミンマレイン酸塩、マボグルラントその他）、用途別分析（クリニック、病院、研究センター）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：AbbVie Inc.、Sellas Inc.、F. Hoffmann-La Roche Ltd.、Addex Therapeutics Ltd、Rottapharm SpA、C4X Discovery Limited、Omeros Corporation、Novartis AG ・企業別売上、市場シェア ・強迫性障害治療の地域別市場分析 ・強迫性障害治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・強迫性障害治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・強迫性障害治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・強迫性障害治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・強迫性障害治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・強迫性障害治療の種類別市場規模2015-2020：ADX-88178、ビトペルチン、CR-5542、Dipraglurant IR、フルボキサミンマレイン酸塩、マボグルラントその他 ・強迫性障害治療の用途別市場規模2015-2020：クリニック、病院、研究センター ・強迫性障害治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Obsessive-Compulsive Disorder Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Obsessive-Compulsive Disorder Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Obsessive-Compulsive Disorder Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Obsessive-Compulsive Disorder Treatment market has been segmented into:
ADX-88178
Bitopertin
CR-5542
Dipraglurant IR
Fluvoxamine Maleate
Mavoglurant
Others

By Application, Obsessive-Compulsive Disorder Treatment has been segmented into:
Clinic
Hospital
Research Center

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Obsessive-Compulsive Disorder Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Obsessive-Compulsive Disorder Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Obsessive-Compulsive Disorder Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Obsessive-Compulsive Disorder Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Obsessive-Compulsive Disorder Treatment Market Share Analysis
Obsessive-Compulsive Disorder Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Obsessive-Compulsive Disorder Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Obsessive-Compulsive Disorder Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Obsessive-Compulsive Disorder Treatment are:
AbbVie Inc.
Sellas Inc.
F. Hoffmann-La Roche Ltd.
Addex Therapeutics Ltd
Rottapharm SpA
C4X Discovery Limited
Omeros Corporation
Novartis AG

レポート目次

---

Table of Contents

1 Obsessive-Compulsive Disorder Treatment Market Overview
1.1 Product Overview and Scope of Obsessive-Compulsive Disorder Treatment
1.2 Classification of Obsessive-Compulsive Disorder Treatment by Type
1.2.1 Global Obsessive-Compulsive Disorder Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by Type in 2019
1.2.3 ADX-88178
1.2.4 Bitopertin
1.2.5 CR-5542
1.2.6 Dipraglurant IR
1.2.7 Fluvoxamine Maleate
1.2.8 Mavoglurant
1.2.9 Others
1.3 Global Obsessive-Compulsive Disorder Treatment Market by Application
1.3.1 Overview: Global Obsessive-Compulsive Disorder Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Research Center
1.4 Global Obsessive-Compulsive Disorder Treatment Market by Regions
1.4.1 Global Obsessive-Compulsive Disorder Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Obsessive-Compulsive Disorder Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Obsessive-Compulsive Disorder Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Obsessive-Compulsive Disorder Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Obsessive-Compulsive Disorder Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Obsessive-Compulsive Disorder Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Obsessive-Compulsive Disorder Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 AbbVie Inc.
2.1.1 AbbVie Inc. Details
2.1.2 AbbVie Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie Inc. SWOT Analysis
2.1.4 AbbVie Inc. Product and Services
2.1.5 AbbVie Inc. Obsessive-Compulsive Disorder Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sellas Inc.
2.2.1 Sellas Inc. Details
2.2.2 Sellas Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sellas Inc. SWOT Analysis
2.2.4 Sellas Inc. Product and Services
2.2.5 Sellas Inc. Obsessive-Compulsive Disorder Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 F. Hoffmann-La Roche Ltd.
2.3.1 F. Hoffmann-La Roche Ltd. Details
2.3.2 F. Hoffmann-La Roche Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 F. Hoffmann-La Roche Ltd. SWOT Analysis
2.3.4 F. Hoffmann-La Roche Ltd. Product and Services
2.3.5 F. Hoffmann-La Roche Ltd. Obsessive-Compulsive Disorder Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Addex Therapeutics Ltd
2.4.1 Addex Therapeutics Ltd Details
2.4.2 Addex Therapeutics Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Addex Therapeutics Ltd SWOT Analysis
2.4.4 Addex Therapeutics Ltd Product and Services
2.4.5 Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Rottapharm SpA
2.5.1 Rottapharm SpA Details
2.5.2 Rottapharm SpA Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Rottapharm SpA SWOT Analysis
2.5.4 Rottapharm SpA Product and Services
2.5.5 Rottapharm SpA Obsessive-Compulsive Disorder Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 C4X Discovery Limited
2.6.1 C4X Discovery Limited Details
2.6.2 C4X Discovery Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 C4X Discovery Limited SWOT Analysis
2.6.4 C4X Discovery Limited Product and Services
2.6.5 C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Omeros Corporation
2.7.1 Omeros Corporation Details
2.7.2 Omeros Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Omeros Corporation SWOT Analysis
2.7.4 Omeros Corporation Product and Services
2.7.5 Omeros Corporation Obsessive-Compulsive Disorder Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis AG SWOT Analysis
2.8.4 Novartis AG Product and Services
2.8.5 Novartis AG Obsessive-Compulsive Disorder Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Obsessive-Compulsive Disorder Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Obsessive-Compulsive Disorder Treatment Players Market Share
3.2.2 Top 10 Obsessive-Compulsive Disorder Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Obsessive-Compulsive Disorder Treatment Revenue and Market Share by Regions
4.2 North America Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
5 North America Obsessive-Compulsive Disorder Treatment Revenue by Countries
5.1 North America Obsessive-Compulsive Disorder Treatment Revenue by Countries (2015-2020)
5.2 USA Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
6 Europe Obsessive-Compulsive Disorder Treatment Revenue by Countries
6.1 Europe Obsessive-Compulsive Disorder Treatment Revenue by Countries (2015-2020)
6.2 Germany Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
6.4 France Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Obsessive-Compulsive Disorder Treatment Revenue by Countries
7.1 Asia-Pacific Obsessive-Compulsive Disorder Treatment Revenue by Countries (2015-2020)
7.2 China Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
7.5 India Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
8 South America Obsessive-Compulsive Disorder Treatment Revenue by Countries
8.1 South America Obsessive-Compulsive Disorder Treatment Revenue by Countries (2015-2020)
8.2 Brazil Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Obsessive-Compulsive Disorder Treatment by Countries
9.1 Middle East & Africa Obsessive-Compulsive Disorder Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Obsessive-Compulsive Disorder Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Obsessive-Compulsive Disorder Treatment Market Forecast by Type (2019-2024)
10.3 ADX-88178 Revenue Growth Rate (2015-2025)
10.4 Bitopertin Revenue Growth Rate (2015-2025)
10.5 CR-5542 Revenue Growth Rate (2015-2025)
10.6 Dipraglurant IR Revenue Growth Rate (2015-2025)
10.7 Fluvoxamine Maleate Revenue Growth Rate (2015-2025)
10.8 Mavoglurant Revenue Growth Rate (2015-2025)
10.9 Others Revenue Growth Rate (2015-2025)
11 Global Obsessive-Compulsive Disorder Treatment Market Segment by Application
11.1 Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by Application (2015-2020)
11.2 Obsessive-Compulsive Disorder Treatment Market Forecast by Application (2019-2024)
11.3 Clinic Revenue Growth (2015-2020)
11.4 Hospital Revenue Growth (2015-2020)
11.5 Research Center Revenue Growth (2015-2020)
12 Global Obsessive-Compulsive Disorder Treatment Market Size Forecast (2021-2025)
12.1 Global Obsessive-Compulsive Disorder Treatment Market Size Forecast (2021-2025)
12.2 Global Obsessive-Compulsive Disorder Treatment Market Forecast by Regions (2021-2025)
12.3 North America Obsessive-Compulsive Disorder Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Obsessive-Compulsive Disorder Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Obsessive-Compulsive Disorder Treatment Revenue Market Forecast (2021-2025)
12.6 South America Obsessive-Compulsive Disorder Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Obsessive-Compulsive Disorder Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Obsessive-Compulsive Disorder Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Obsessive-Compulsive Disorder Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Obsessive-Compulsive Disorder Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Obsessive-Compulsive Disorder Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AbbVie Inc. Corporate Information, Location and Competitors
Table 6. AbbVie Inc. Obsessive-Compulsive Disorder Treatment Major Business
Table 7. AbbVie Inc. Obsessive-Compulsive Disorder Treatment Total Revenue (USD Million) (2017-2018)
Table 8. AbbVie Inc. SWOT Analysis
Table 9. AbbVie Inc. Obsessive-Compulsive Disorder Treatment Product and Solutions
Table 10. AbbVie Inc. Obsessive-Compulsive Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sellas Inc. Corporate Information, Location and Competitors
Table 12. Sellas Inc. Obsessive-Compulsive Disorder Treatment Major Business
Table 13. Sellas Inc. Obsessive-Compulsive Disorder Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Sellas Inc. SWOT Analysis
Table 15. Sellas Inc. Obsessive-Compulsive Disorder Treatment Product and Solutions
Table 16. Sellas Inc. Obsessive-Compulsive Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. F. Hoffmann-La Roche Ltd. Corporate Information, Location and Competitors
Table 18. F. Hoffmann-La Roche Ltd. Obsessive-Compulsive Disorder Treatment Major Business
Table 19. F. Hoffmann-La Roche Ltd. Obsessive-Compulsive Disorder Treatment Total Revenue (USD Million) (2017-2018)
Table 20. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 21. F. Hoffmann-La Roche Ltd. Obsessive-Compulsive Disorder Treatment Product and Solutions
Table 22. F. Hoffmann-La Roche Ltd. Obsessive-Compulsive Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Addex Therapeutics Ltd Corporate Information, Location and Competitors
Table 24. Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Major Business
Table 25. Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Addex Therapeutics Ltd SWOT Analysis
Table 27. Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Product and Solutions
Table 28. Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Rottapharm SpA Corporate Information, Location and Competitors
Table 30. Rottapharm SpA Obsessive-Compulsive Disorder Treatment Major Business
Table 31. Rottapharm SpA Obsessive-Compulsive Disorder Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Rottapharm SpA SWOT Analysis
Table 33. Rottapharm SpA Obsessive-Compulsive Disorder Treatment Product and Solutions
Table 34. Rottapharm SpA Obsessive-Compulsive Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. C4X Discovery Limited Corporate Information, Location and Competitors
Table 36. C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Major Business
Table 37. C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Total Revenue (USD Million) (2017-2018)
Table 38. C4X Discovery Limited SWOT Analysis
Table 39. C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Product and Solutions
Table 40. C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Omeros Corporation Corporate Information, Location and Competitors
Table 42. Omeros Corporation Obsessive-Compulsive Disorder Treatment Major Business
Table 43. Omeros Corporation Obsessive-Compulsive Disorder Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Omeros Corporation SWOT Analysis
Table 45. Omeros Corporation Obsessive-Compulsive Disorder Treatment Product and Solutions
Table 46. Omeros Corporation Obsessive-Compulsive Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Novartis AG Corporate Information, Location and Competitors
Table 48. Novartis AG Obsessive-Compulsive Disorder Treatment Major Business
Table 49. Novartis AG Obsessive-Compulsive Disorder Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Novartis AG SWOT Analysis
Table 51. Novartis AG Obsessive-Compulsive Disorder Treatment Product and Solutions
Table 52. Novartis AG Obsessive-Compulsive Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by Players (2015-2020)
Table 54. Global Obsessive-Compulsive Disorder Treatment Revenue Share by Players (2015-2020)
Table 55. Global Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by Regions (2015-2020)
Table 57. North America Obsessive-Compulsive Disorder Treatment Revenue by Countries (2015-2020)
Table 58. North America Obsessive-Compulsive Disorder Treatment Revenue Market Share by Countries (2015-2020)
Table 59. Europe Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Obsessive-Compulsive Disorder Treatment Revenue by Countries (2015-2020)
Table 62. South America Obsessive-Compulsive Disorder Treatment Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Obsessive-Compulsive Disorder Treatment Revenue Market Share by Countries (2015-2020)
Table 65. Global Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by Type (2015-2020)
Table 66. Global Obsessive-Compulsive Disorder Treatment Revenue Share by Type (2015-2020)
Table 67. Global Obsessive-Compulsive Disorder Treatment Revenue Forecast by Type (2021-2025)
Table 68. Global Obsessive-Compulsive Disorder Treatment Revenue by Application (2015-2020)
Table 69. Global Obsessive-Compulsive Disorder Treatment Revenue Share by Application (2015-2020)
Table 70. Global Obsessive-Compulsive Disorder Treatment Revenue Forecast by Application (2021-2025)
Table 71. Global Obsessive-Compulsive Disorder Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Obsessive-Compulsive Disorder Treatment Picture
Figure 2. Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by Type in 2019
Figure 3. ADX-88178 Picture
Figure 4. Bitopertin Picture
Figure 5. CR-5542 Picture
Figure 6. Dipraglurant IR Picture
Figure 7. Fluvoxamine Maleate Picture
Figure 8. Mavoglurant Picture
Figure 9. Others Picture
Figure 10. Obsessive-Compulsive Disorder Treatment Revenue Market Share by Application in 2019
Figure 11. Clinic Picture
Figure 12. Hospital Picture
Figure 13. Research Center Picture
Figure 14. Global Obsessive-Compulsive Disorder Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Obsessive-Compulsive Disorder Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Obsessive-Compulsive Disorder Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Obsessive-Compulsive Disorder Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Obsessive-Compulsive Disorder Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Obsessive-Compulsive Disorder Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Obsessive-Compulsive Disorder Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Obsessive-Compulsive Disorder Treatment Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Obsessive-Compulsive Disorder Treatment Revenue Market Share in 2019
Figure 23. Global Top 10 Players Obsessive-Compulsive Disorder Treatment Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Obsessive-Compulsive Disorder Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by Regions (2015-2020)
Figure 27. Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by Regions in 2018
Figure 28. North America Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Europe Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 31. South America Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 33. North America Obsessive-Compulsive Disorder Treatment Revenue Market Share by Countries (2015-2020)
Figure 34. North America Obsessive-Compulsive Disorder Treatment Revenue Market Share by Countries in 2019
Figure 35. USA Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Canada Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Europe Obsessive-Compulsive Disorder Treatment Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Obsessive-Compulsive Disorder Treatment Revenue Market Share by Countries in 2019
Figure 40. Germany Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 41. UK Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 42. France Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Russia Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Italy Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Obsessive-Compulsive Disorder Treatment Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Obsessive-Compulsive Disorder Treatment Revenue Market Share by Countries in 2019
Figure 47. China Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Japan Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Korea Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 50. India Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 52. South America Obsessive-Compulsive Disorder Treatment Revenue Market Share by Countries (2015-2020)
Figure 53. South America Obsessive-Compulsive Disorder Treatment Revenue Market Share by Countries in 2019
Figure 54. Brazil Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Obsessive-Compulsive Disorder Treatment Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Obsessive-Compulsive Disorder Treatment Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 59. UAE Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Obsessive-Compulsive Disorder Treatment Revenue and Growth Rate (2015-2020)
Figure 62. Global Obsessive-Compulsive Disorder Treatment Revenue Share by Type (2015-2020)
Figure 63. Global Obsessive-Compulsive Disorder Treatment Revenue Share by Type in 2019
Figure 64. Global Obsessive-Compulsive Disorder Treatment Market Share Forecast by Type (2021-2025)
Figure 65. Global ADX-88178 Revenue Growth Rate (2015-2020)
Figure 66. Global Bitopertin Revenue Growth Rate (2015-2020)
Figure 67. Global CR-5542 Revenue Growth Rate (2015-2020)
Figure 68. Global Dipraglurant IR Revenue Growth Rate (2015-2020)
Figure 69. Global Fluvoxamine Maleate Revenue Growth Rate (2015-2020)
Figure 70. Global Mavoglurant Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Obsessive-Compulsive Disorder Treatment Revenue Share by Application (2015-2020)
Figure 73. Global Obsessive-Compulsive Disorder Treatment Revenue Share by Application in 2019
Figure 74. Global Obsessive-Compulsive Disorder Treatment Market Share Forecast by Application (2021-2025)
Figure 75. Global Clinic Revenue Growth Rate (2015-2020)
Figure 76. Global Hospital Revenue Growth Rate (2015-2020)
Figure 77. Global Research Center Revenue Growth Rate (2015-2020)
Figure 78. Global Obsessive-Compulsive Disorder Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Obsessive-Compulsive Disorder Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Obsessive-Compulsive Disorder Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Obsessive-Compulsive Disorder Treatment Revenue Market Forecast (2021-2025)
Figure 82. Europe Obsessive-Compulsive Disorder Treatment Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Obsessive-Compulsive Disorder Treatment Revenue Market Forecast (2021-2025)
Figure 84. South America Obsessive-Compulsive Disorder Treatment Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Obsessive-Compulsive Disorder Treatment Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel

---